Filing Details
RESMED INC (NYSE:RMD) filed its annual report (Form 10-K) with the Securities and Exchange Commission on August 13, 2026.
The Healthcare company's annual report covers fiscal year 2026.
10k filedNYSE:RMD
RESMED INC (RMD) Files Annual Report with SEC
RESMED INC (NYSE:RMD) filed its annual report (Form 10-K) with the Securities and Exchange Commission on August 13, 2026.
At publication ·
What changed
RESMED INC (NYSE:RMD) · 10k filed
- Form
- 10-K
At a glance
Key takeaways
- ResMed Inc filed its fiscal year 2026 annual report (Form 10-K) with the SEC on August 13, 2026.
- The company's stock trades at $226.74 with a market capitalization of $37.0 billion.
- The 10-K filing contains detailed financial statements, management discussion and analysis, risk factors, and business segment information that provide more comprehensive disclosure than quarterly reports.
Market Context
RESMED INC's stock currently trades at $226.74 with a market capitalization of $37.0B.
The 10-K is the most comprehensive annual report a public company files, containing detailed financial statements, management discussion and analysis (MD&A), risk factors, and business segment breakdowns. For RESMED INC investors, the 10-K provides depth that quarterly reports don't — including full-year trends, long-term debt schedules, and off-balance-sheet items.
Key sections to review: MD&A for management's narrative on performance, risk factors for newly disclosed threats, and the notes to financial statements for accounting changes that could affect reported earnings.
All SEC filings for RESMED INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View RMD Stock Page
Frequently Asked Questions
Where can I read RMD's SEC filings?
Browse all filings on our RMD SEC filings page.
What types of SEC filings does RESMED INC file?
Public companies like RESMED INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
